Transcutaneous Electrical Nerve Stimulation (TENS) for Primary Dysmenorrhea: An Overview

Michal Elboim-Gabyzon, Leonid Kalichman, Michal Elboim-Gabyzon, Leonid Kalichman

Abstract

Primary dysmenorrhea is a chronic health condition that affects primarily young women. Transcutaneous electrical nerve stimulation (TENS) has been suggested as an effective pain reduction modality in primary dysmenorrhea. TENS is a noninvasive, inexpensive, portable method with minimal risks and a few contraindications. When necessary, it can be self-administered on a daily basis during everyday activities. Several studies have investigated the effectiveness of TENS in reducing pain, decreasing the use of analgesics, and improving the quality of life in primary dysmenorrhea patients. These studies have some limitations in methodological quality and therapeutic validation. However, the overall positive effects of TENS in primary dysmenorrhea encountered in all prior studies indicated its potential value. This review presents the clinical recommendations for TENS parameters for treating primary dysmenorrhea symptoms based on previously published studies.

Keywords: TENS; life quality; pain; primary dysmenorrhea; transcutaneous electrical nerve stimulation; treatment.

Conflict of interest statement

The authors report no conflicts of interest in this work.

© 2020 Elboim-Gabyzon and Kalichman.

Figures

Figure 1
Figure 1
Summary of recommendations for transcutaneous electrical nerve stimulation (TENS) in primary dysmenorrhea.

References

    1. Lefebvre G, Pinsonneault O, Antao V, et al. Primary dysmenorrhea consensus guideline. Can J Obstet Gynaecol. 2005;27(12):1117–1146.
    1. Kannan P, Chapple CM, Miller D, Claydon LS, Baxter GD. Menstrual pain and quality of life in women with primary dysmenorrhea: rationale, design, and interventions of a randomized controlled trial of effects of a treadmill-based exercise intervention. Contemp Clin Trials. 2015;42:81–89. doi:10.1016/j.cct.2015.03.010
    1. Milsom I, Hedner N, Mannheimer C. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea. Am J Obstet Gynecol. 1994;170(1):123–129. doi:10.1016/s0002-9378(94)70396-5
    1. Proctor M, Farquhar C, Stones W, He L, Zhu X, Brown J. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea. Cochrane Database Syst Rev. 2002;1:CD002123.
    1. Bai H-Y, Bai H-Y, Yang Z-Q. Effect of transcutaneous electrical nerve stimulation therapy for the treatment of primary dysmenorrheal. Med. 2017;96(36):e7959. doi:10.1097/MD.0000000000007959
    1. Lauretti GR, Oliveira R, Parada F, Mattos AL. The new portable transcutaneous electrical nerve stimulation device was efficacious in the control of primary dysmenorrhea cramp pain. Neuromodulation. 2015;18(6):522–527. doi:10.1111/ner.12269
    1. Parsa P, Bashirian S. Effect of transcutaneous electrical nerve stimulation (TENS) on primary dysmenorrhea in adolescent girls. J Postgrad Med Inst (Peshawar-Pakistan). 2013;27(3):326–330.
    1. Schiøtz H, Jettestad M, Al-Heeti D. Treatment of dysmenorrhoea with a new TENS device (OVA). J Obstet Gynaecol. 2007;27(7):726–728. doi:10.1080/01443610701612805
    1. Tugay N, Akbayrak T, Demirtürk F, et al. Effectiveness of transcutaneous electrical nerve stimulation and interferential current in primary dysmenorrhea. Pain Med. 2007;8(4):295–300. doi:10.1111/j.1526-4637.2007.00308.x
    1. Wang SF, Lee JP, Hwa HL. Effect of transcutaneous electrical nerve stimulation on primary dysmenorrhea. Neuromodulation. 2009;12(4):302–309. doi:10.1111/j.1525-1403.2009.00226.x
    1. Kannan P, Claydon LS. Some physiotherapy treatments may relieve menstrual pain in women with primary dysmenorrhea: a systematic review. J Physiother. 2014;60(1):13–21. doi:10.1016/j.jphys.2013.12.003
    1. Latthe P, champaneria R, Khan KS. Dysmenorrhoea. BMJ Clin Evid. 2011;21:2011.
    1. Maybin JA, Critchley HO. Menstrual physiology: implications for endometrial pathology and beyond. Hum Reprod Update. 2015;21(6):748–761. doi:10.1093/humupd/dmv038
    1. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(3699):971–979. doi:10.1126/science.150.3699.971
    1. Vance CG, Dailey DL, Rakel BA, Sluka KA. Using TENS for pain control: the state of the evidence. Pain Manag. 2014;4(3):197–209. doi:10.2217/pmt.14.13
    1. Lewers D, Clelland JA, Jackson JR, Varner RE, Bergman J. Transcutaneous electrical nerve stimulation in the relief of primary dysmenorrhea. Phys Ther. 1989;69(1):3–9. doi:10.1093/ptj/69.1.3
    1. Mannheimer JS, Whalen EC. The efficacy of transcutaneous electrical nerve stimulation in dysmenorrhea. Clin J Pain. 1985;1(2):75–84. doi:10.1097/00002508-198501020-00004
    1. Dawood MY, Ramos J. Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen. Obstet Gynecol. 1990;75(4):656–660.
    1. Lundeberg T, Bondesson L, Lundströom V. Relief of primary dysmenorrhea by transcutaneous electrical nerve stimulation. Acta Obstet Gynecol Scand. 1985;64(6):491–497. doi:10.3109/00016348509156727
    1. Neighbors LE, Clelland J, Jackson JR, Bergman J, Orr JJ. Transcutaneous electrical nerve stimulation for pain relief in primary dysmenorrhea. Clin J Pain. 1987;3(1):17–22. doi:10.1097/00002508-198703010-00004
    1. Sluka KA, Bjordal JM, Marchand S, Rakel BA. What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Phys Ther. 2013;93(10):1397–1402. doi:10.2522/ptj.20120281
    1. Kitchen S, Bazin S, Bellis E. Electrotherapy: Evidence-Based Practice. 11th ed. London, UK: Churchill Livingstone; 2002.
    1. Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003;4(3):109–121. doi:10.1054/jpai.2003.434
    1. Bjordal JM, Johnson MI, Ljunggreen AE. Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters for postoperative pain. Eur J Pain. 2003;7(2):181–188. doi:10.1016/S1090-3801(02)00098-8
    1. Moran F, Leonard T, Hawthorne S, et al. Hypoalgesia in response to transcutaneous electrical nerve stimulation (TENS) depends on stimulation intensity. J Pain. 2011;12(8):929–935. doi:10.1016/j.jpain.2011.02.352
    1. Cameron MH. Physical Agents in Rehabilitation: From Research to Practice. Elsevier Health Sciences; 2012.
    1. Robinson AJ. Clinical Electrophysiology: Electrotherapy and Electrophysiologic Testing. Lippincott Williams & Wilkins; 2008.
    1. Spielholz N, Nolan M. Conventional TENS and the phenomenon of accommodation, adaptation, habituation and electrode polarization. J Clin Electrophysiol. 1995;7:16–19.
    1. Pantaleao MA, Laurino MF, Gallego NL, et al. Adjusting pulse amplitude during transcutaneous electrical nerve stimulation (TENS) application produces greater hypoalgesia. J Pain. 2011;12(5):581–590. doi:10.1016/j.jpain.2010.11.001
    1. Cheing GL, Hui-Chan CW, Chan K. Does four weeks of TENS and/or isometric exercise produce cumulative reduction of osteoarthritic knee pain? Clin Rehabil. 2002;16(7):749–760. doi:10.1191/0269215502cr549oa
    1. Liebano RE, Rakel B, Vance CG, Walsh DM, Sluka KA. An investigation of the development of analgesic tolerance to TENS in humans. Pain. 2011;152(2):335–342. doi:10.1016/j.pain.2010.10.040
    1. Sato KL, Sanada LS, Rakel BA, Sluka KA. Increasing intensity of TENS prevents analgesic tolerance in rats. J Pain. 2012;13(9):884–890. doi:10.1016/j.jpain.2012.06.004
    1. Chabal C, Fishbain DA, Weaver M, Heine LW. Long-term transcutaneous electrical nerve stimulation (TENS) use: impact on medication utilization and physical therapy costs. Clin J Pain. 1998;14(1):66–73. doi:10.1097/00002508-199803000-00010
    1. Fishbain DA, Chabal C, Abbott A, Heine LW, Cutler R. Transcutaneous electrical nerve stimulation (TENS) treatment outcome in long-term users. Clin J Pain. 1996;12(3):201–214. doi:10.1097/00002508-199609000-00008
    1. Johnson M, Ashton C, Thompson J. Long term use of transcutaneous electrical nerve stimulation at Newcastle Pain Relief Clinic. J R Soc Med. 1992;85(5):267.
    1. Oosterhof J, Wilder‐Smith OH, de Boo T, et al. The long-term outcome of transcutaneous electrical nerve stimulation in the treatment for patients with chronic pain: a randomized, placebo-controlled trial. Pain Pract. 2012;12(7):513–522. doi:10.1111/j.1533-2500.2012.00533.x
    1. Léonard G, Cloutier C, Marchand S. Reduced analgesic effect of acupuncture-like TENS but not conventional TENS in opioid-treated patients. J Pain. 2011;12(2):213–221. doi:10.1016/j.jpain.2010.07.003
    1. Turk D, Dworkin R, Burke L, et al. Initiative on methods, measurement and pain assessment in clinical trials. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain. 2006;125(3):208–215. doi:10.1016/j.pain.2006.09.028
    1. Dailey DL, Rakel BA, Vance CG, et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. PAIN®. 2013;154(11):2554–2562. doi:10.1016/j.pain.2013.07.043

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner